1. Antibody Engineering & Therapeutics
2. Inhalation & Respiratory Drug Delivery
3. Pharmacovigilance & Drug Safety
4. Pre-filled Syringes & Injectables
5. Gut-Brain Axis
6. Probiotics, Human & Skin Microbiome
7. Aseptic Processing Technology
8. CDx/Biomarkers & Biobanking

Day 1

Day 2

Day 1 | 08:00 - 08:20

Registration & Welcome Coffee

Day 2 | 08:00 - 08:20

Registration and Coffee

Day 1 | 08:20 - 08:30

Chairman's Opening Address

Day 2 | 08:20 - 08:30

Chairman's Opening Address

Day 1 | 08:30 - 09:00

Antibody Manufacturing Strategies during a Pandemic
Nick Hutchinson, Business Steering Group Lead for Mammalian Cell Culture Services at FUJIFILM Diosynth Biotechnologies

Day 2 | 08:30 - 09:00

Responding to the COVID-19 Pandemic with Antibodies, Small Molecules Drugs and Vaccines
Kevin Heyries, Ph.D. Co-founder and Head of Business Development at AbCellera

Day 1 | 09:00 - 09:30

Speed Networking
An innovative approach to maximize networking capabilities through two minute periods, where delegates can meet their peers and exchange business cards before rotating to the next company representative.

Day 2 | 09:00 - 09:30

Topic to be announced
Vu Truong, Ph.D. Founder, Chief Executive Officer, and Director at Aridis Pharmaceuticals, Inc.

Day 1 | 09:30 - 10:00

Heavy Chain Only Antibodies to SARS-CoV-2
Kathryn H. Ching, Research Investigator at Ligand Pharmaceuticals Incorporated

Day 2 | 09:30 - 10:00

Topic to be announced
Dr. Katharina Billian-Frey, Head of Protein Engineering at Apogenix AG

Day 1 | 10:00 - 10:30

Topic to be announced
Monica Berrondo, CEO at Macromoltek

Day 2 | 10:00 - 10:30

The art of making multifunctional antibodies: therapeutic opportunities and technical challenges
Harald Kolmar, Ph.D. Department Head and Professor of Applied Biochemistry at Technical University of Darmstadt
10:30 - 11:00

Morning Coffee & Networking Break

Day 1 | 11:00 - 11:30
Antibiotic Discovery by Means of Computers
César de la Fuente, Ph.D. Presidential Assistant Professor at UPenn
Day 2 | 11:00 - 11:30
Challenges in characterization and developability of multispecific antibodies
Soraya Hölper, PhD Lab Head Mass Spectrometry at Sanofi
Day 1 | 11:30 - 12:00
Designing and Developing Next-Generation Antibody-Drug Conjugate Medicines
Nicolas Camper, Group Leader, Bioconjugation Chemistry at Abzena
Day 2 | 11:30 - 12:00
Modulating the Immune System with Multi-Specific Antibodies in Cancer
Katherine Harris Vice President, Discovery at Teneobio, Inc.
Day 1 | 12:00 - 12:30
Lessons in Discovering Antibodies against GPCRs, Ion Channels, and Transporters
Benjamin Doranz, PhD, MBA President & CEO at Integral Molecular
Day 2 | 12:00 - 13:00
Panel Discussion
Antibody Selection and Screening in Early Discovery
Day 1 | 12:30 - 13:00
Developing next-generation therapeutic proteins as highly targeted therapies in immuno-oncology and respiratory disease
Hitto Kaufmann, Chief Scientific Officer, Senior VP bei Pieris Pharmaceuticals
13:00 - 14:00

Lunch Break

Day 1 | 14:00 - 14:30
Discovery and engineering of Immuno-oncology antibodies – Effective formats and impactful combinations
Marc A. van Dijk, Chief Technology Officer at Agenus Inc
Day 2 | 14:00 - 14:30
TOP-5 Poster Presentations (5min. On Stage)
Click here to submit your Poster
Day 1 | 14:30 - 15:00
Topic to be announced
Yasmina Abdiche, Chief Scientific Officer at ImmunoPrecise Antibodies
Day 2 | 14:30 - 15:00
Bispecific γδ-T cell engagers for the treatment of cancer
Paul W.H.I. Parren, PhD, Executive Vice President and Head of R&D at Lava Therapeutics
15:00 - 15:30

Afternoon Coffee & Networking Break

Day 1 | 15:30 - 16:00
GEMS-TM system - a plug-and-play system for biomanufacturing
Sicco H. Popma, President & CEO at IO Biosciences
Day 2 | 15:30 - 16:00
Neo-X’: A bispecific antibody concept targeting CD40 and tumor antigens to enhance neoantigen cross-presentation and T cell priming.
Mattias Levin Sr Scientist, Antibody Engineering at Alligator Bioscience
Day 1 | 16:00 - 16:30
Antibody-targeted cytoplasmic delivery of fusion proteins and antibody fragments using Sapreme’s endosomal escape enhancers
Miriam Bujny Chief Development Officer (CDO) at Sapreme Technologies
Day 2 | 16:00 - 16:30
Affinity maturation of B7-H6 translates into enhanced NK cell-mediated tumor cell lysis and improved proinflammatory cytokine release of bispecific immunoligands via NKp30 engagement
Stefan Zielonka Associate Director at Merck KGaA
Day 1 | 16:30 - 17:00
Topic to be announced
Heather Schwoebel, Senior Vice President of BD, Head of Platform Licensing at Alloy Therapeutics, Inc.
Day 2 | 16:30
Chairman's closing remarks & End of the IRDD Event
Day 1 | 17:00 - 17:30
Topic to be announced
Oren Beske, Ph.D. Amalgamator of Business and Biology at ATUM
Day 1 | 17:30 - 18:00
Panel Discussion
Computational Modeling of Antibody-Antigen Interactions

DAY 1 | 20:00 - 22:30

Monday night business dinner

The BioTech Pharma Summit 2021: Gala Dinner

Sponsor this event - Click here
IRDD_Gala_Dinner_New_York_Inhalation_Drug_Delivery

Day 1

Day 2

Day 1 | 08:00 - 08:20

Registration & Welcome Coffee

Day 2 | 08:00 - 08:20

Registration and Coffee

Day 1 | 08:20 - 08:30

Chairman's Opening Address

Day 2 | 08:20 - 08:30

Chairman's Opening Address

Part I: The challenges of developing inhalation drugs

Part V: New Approaches to Treating Respiratory Diseases

Day 1 | 08:30 - 09:00

Science base and challenges of therapeutic equivalence of respiratory products.
Jörg Schiewe, Head of Global CMC Experts at Boehringer Ingelheim Pharma GmbH & Co. KG

Day 2 | 08:30 - 09:00

Topic to announce

Masahiro Sakagami, Professor of Pharmaceutics at Virginia Commonwealth University School of Pharmacy

Day 1 | 09:00 - 09:30

Speed Networking
An innovative approach to maximize networking capabilities through two minute periods, where delegates can meet their peers and exchange business cards before rotating to the next company representative.

Day 2 | 09:00 - 09:30

Shared Decision Making to Improve Adherence in Severe Asthma

Tonya Winders, President and Chief Executive Officer at Allergy & Asthma Network

Day 1 | 09:30 - 10:00

The biological barriers to consider for the development of inhaled biotherapeutics
Nathalie Heuzé-Vourc'h, Research Professor at INSERM, Research Centre for Respiratory Diseases

Day 2 | 09:30 - 10:00

Inhalation therapy for pulmonary arterial hypertension, a pulmonary vascular disease
Fakhrul Ahsan, University Distinguished Professor in the Department of Pharmaceutical Sciences at the TTUHSC

Day 1 | 10:00 - 10:30

Early Phase Clinical Trials for Inhaled Drugs - Challenges and Opportunities
Aernout van Haarst, PhD Director, Scientific Affairs at Celerion

Day 2 | 10:00 - 10:30

Optimising surrogate outcome measures for respiratory trials
Peter Robbins Professor of Physiology at the University of Oxford
10:30 - 11:00

Morning Coffee & Networking Break

Part VI: New analytical insights into dry powder formulations for inhalation

Day 1 | 11:00 - 11:30
Accurate dosimetry predictions for evolving liquid aerosol delivery
Arkadiusz Kuczaj, PhD, Manager Aerosol Research and Dosimetry at Philip Morris International Research and Development
Day 2 | 11:00 - 11:30
Topic to announce

Wayland Rushing, Director, Scientific Affairs at Eurofins BioPharma Product Testing

Part II: Inhalation Formulation Solutions & Technology

Day 1 | 11:30 - 12:00
High Dosage DPI – formulation and process development considerations
Beatriz Noriega Fernandes, Scientist, Formulation Group - Drug Product Development at Hovione
Day 2 | 11:30 - 12:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 1 | 12:00 - 12:30
Administration of high dose antibiotic DPI: formulation/device combination for a cystic fibrosis patient-centric product
Francesca Buttini, Associate Professor at University of Parma, Italy
Day 2 | 12:00 - 13:00
Panel Discussion
Future directions in inhalation and respiratory drug delivery research
Day 1 | 12:30 - 13:00
Musings on High Dose Powder Delivery
Jeffry Weers, Ph.D. Chief Technical Officer at Respira Therapeutics, Inc.
13:00 - 14:00

Lunch Break

Day 1 | 14:00 - 14:30
Increasing the drug load in capsule based DPI drug delivery systems
Prof. Dr. Sven Stegemann, Professor of patient centric drug design and manufacturing at the Graz University of Technology, Austria
Day 2 | 14:00 - 14:30
TOP-5 Poster Presentations (5min. On Stage)
Click here to submit your Poster

Part V: New Approaches to Inhalation Product Development and Production

Day 1 | 14:30 - 15:00
Formulation Development Challenges and Pitfalls When Developing Dry Powder Inhalers
Martin Wing-King, Director of Project Management at Quotient Sciences
Day 2 | 14:30 - 15:00
Topic to be announced (Development and commercialization of inhaled therapeutic products)
Michael Castagna, Chief Executive Officer at MannKind Corporation
15:00 - 15:30

Afternoon Coffee & Networking Break

Part IV: Regulatory pathways for inhaled therapies

Day 1 | 15:30 - 16:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 2 | 15:30 - 16:00
Development of an Integrated Digital Health Product (DigihalerTM)
Mark Milton-Edwards Head of Product & Health Solutions - Digital Health at Teva Pharmaceuticals
Day 1 | 16:00 - 16:30
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 2 | 16:00 - 16:30
Use of 3d printing, Computational fluid dynamics and customised engineering in inhalation pre-clinical development
Simon Moore, Global Lead of Inhalation Science and Engineering at Covance
Day 1 | 16:30 - 17:00
Get it right first time: Inhaler technology and manufacturing
Marco Laackmann, Director Inhalation Technology at Harro Höfliger
Day 2 | 16:30
Chairman's closing remarks & End of the IRDD Event

Part III: Regulatory pathways for inhaled therapies

Day 1 | 17:00 - 17:30
Using a New Human Realistic Approach to In Vitro Characterization to Better Predict In Vivo Performance of Inhaled Aerosols
Dino Farina, Founder and CEO at Proveris Scientific
Day 1 | 17:30 - 18:00
Panel Discussion
Asthma inhalers: what next for the drug delivery tech?

DAY 1 | 20:00 - 22:30

Monday night business dinner

The BioTech Pharma Summit 2021: Gala Dinner

Sponsor this event - Click here
IRDD_Gala_Dinner_New_York_Inhalation_Drug_Delivery

Day 1

Day 2

Day 1 | 08:00 - 08:20

Registration & Welcome Coffee

Day 2 | 08:00 - 08:20

Registration and Coffee

Day 1 | 08:20 - 08:30

Chairman's Opening Address

Day 2 | 08:20 - 08:30

Chairman's Opening Address

Day 1 | 08:30 - 09:00

PSMF in a global environment: compliance with local requirements
Margherita D'Antuono, Corporate Pharmacovigilance Director - EU QPPV at Italfarmaco Group

Day 2 | 08:30 - 09:00

Patients and consumers involvement in Pharmacovigilance systems - challenges and opportunities
Sílvia Teles Duarte, Pharmacovigilance procedure manager at Infarmed

Day 1 | 09:00 - 09:30

Speed Networking
An innovative approach to maximize networking capabilities through two minute periods, where delegates can meet their peers and exchange business cards before rotating to the next company representative.

Day 2 | 09:00 - 09:30

Topic to be announced
Uwe Gudat, Head of Medical Affairs & CSPV at Fresenius Kabi at Fresenius Kabi SwissBioSim GmbH

Day 1 | 09:30 - 10:00

How to achieve 3S pharmacovigilance (smart, strategic, selective): view from the generic sector
Susana Almeida, Clinical Development and Safety Director at Medicines for Europe

Day 2 | 09:30 - 10:00

New Trends in Signal Detection and Management
Robert Weber, Product Management Director at Oracle

Day 1 | 10:00 - 10:30

Adoption of Artificial Intelligence in Pharmacovigilance: a framework for the development of cognitive services and the role of the Drug Safety Professional
Salvatore Cicirello, Head of Safety Science & PASS, Global Drug Safety & Risk Management at Bristol Myers Squibb

Day 2 | 10:00 - 10:30

Stop processing and start analysing - Pharmacovigilance moves into the modern age
Graeme Ladds, CEO at PharSafer
10:30 - 11:00

Morning Coffee & Networking Break

Day 1 | 11:00 - 11:30
Digital Media, marketing projects, e-commerce and other business initiatives: opportunities and challenges for PV
Valentina Mancini, Director PV, EU QPPV at Shionogi Europe
Day 2 | 11:00 - 11:30
Cardiovascular safety issues during phase III-IV for non-cardiovascular trials.
Anupam Agarwal, Vice President, Global Head of Drug Safety and Pharmacovigilance at Zogenix, Inc.
Day 1 | 11:30 - 12:00
How Pharmacovigilance could support business
Andrea Oliva, Head of Pharmacovigilance at Mylan
Day 2 | 11:30 - 12:00
Topic to be announced
Mircea Ciuca, Global Therapeutic Area Head - Global Clinical Safety and Pharmacovigilance at CSL Behring
Day 1 | 12:00 - 12:30
How to define PV strategy and build an effective Regulatory Intelligence function
Julia Appelskog, Pharmacovigilance Director, EU QPPV, Head of QPPVs & Safety Consulting Services at TFS
Day 2 | 12:00 - 13:00
Panel Discussion
Topic to be announced
Day 1 | 12:30 - 13:00
Post authorization safety studies (PASS)
Massoud Toussi, Senior Principal, Real World Evidence Solutions at IQVIA
13:00 - 14:00

Lunch Break

Day 1 | 14:00 - 14:30
A framework for Safety evaluation and risk managment
Tjark Reblin, Global Head of Product Safety and Risk Management at Vifor Pharma Group
Day 2 | 14:00 - 14:30
TOP-5 Poster Presentations (5min. On Stage)
Click here to submit your Poster
Day 1 | 14:30 - 15:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 2 | 14:30 - 15:00
Speaking Sponsorship Available - Have your talk here
Click here to register
15:00 - 15:30

Afternoon Coffee & Networking Break

Day 1 | 15:30 - 16:00
Structured and Quantitative Benefit-Risk evaluation for medicinal products: how can it make a difference?
Marie-Laure Kürzinger, Benefit-Risk Expert - Global Epidemiology & Benefit-Risk Evaluation - Global Pharmacovigilance at Sanofi
Day 2 | 15:30 - 16:00
Topic to be announced
Martin Holm-Petersen, CEO at Insife
Day 1 | 16:00 - 16:30
EudraVigilance, XEVMPD, EVDAS, SPOR, EMA unique account news
Calin Lungu, CEO at DDCS S.A.
Day 2 | 16:00 - 16:30
Topic to be announced
Budhesh Dhamija, Senior Manager, Regulatory Intelligence and Policy – Europe at CSL Behring
Day 1 | 16:30 - 17:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 2 | 16:30
Chairman's closing remarks & End of the IRDD Event
Day 1 | 17:00 - 17:30
Panel Discussion
Topic to be announced

DAY 1 | 20:00 - 22:30

Monday night business dinner

The BioTech Pharma Summit 2021: Gala Dinner

Sponsor this event - Click here
IRDD_Gala_Dinner_New_York_Inhalation_Drug_Delivery

Pre-filled Syringes & Injectables Agenda

Agenda is being produced and will be announced soon.
Click here to speak at this event
Click here to find the Confirmed speakers
C0245.00_06_51_18.Quadro020

Day 1

Day 2

Day 1 | 08:00 - 08:20

Registration & Welcome Coffee

Day 2 | 08:00 - 08:20

Registration and Coffee

Day 1 | 08:20 - 08:30

Chairman's Opening Address

Day 2 | 08:20 - 08:30

Chairman's Opening Address

Day 1 | 08:30 - 09:00

Gut brain axis and neurological diseases
Pierre Lestage, Chief Executive Officer at NeribiOm

Day 2 | 08:30 - 09:00

Harnessing the Potential of Microbiota-related Therapies for Brain Health
Jane A. Foster, Associate Professor at McMaster University

Day 1 | 09:00 - 09:30

Gut-Brain Axis Speed Networking
An innovative approach to maximize networking capabilities through two minute periods, where delegates can meet their peers and exchange business cards before rotating to the next company representative.

Day 2 | 09:00 - 09:30

Deciphering the Gut-Microbiome-Brain Axis Relationship with Metabolomics
Rohan F. Hastie, Ph.D. President & Chief Executive Officer at Metabolon

Day 1 | 09:30 - 10:00

Speaking Sponsorship Available - Have your talk here
Click here to register

Day 2 | 09:30 - 10:00

Intestinal microbiome medicinal product (IMMP): establishing a licensed platform to create novel products
Christian Roghi, Director of Strategic Alliances at CosmosID

Day 1 | 10:00 - 10:30

Do plant-derived exosomes regulate the gut microbiome?
Jennifer K. Spinler, Instructor at Texas Children’s Microbiome Center & Baylor College of Medicine

Day 2 | 10:00 - 10:30

To be announced
Martha Carlin, Chief Executive Officer at The BioCollective
10:30 - 11:00

Morning Coffee & Networking Break

Day 1 | 11:00 - 11:30
Topic to be announced
Rochellys Diaz Heijtz, Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet
Day 2 | 11:00 - 11:30
Microbiome Mediated Appetite Regulation - First Experiences with EnteroSatys
Dr. Sergueï O. Fetissov Professor of physiology at Rouen University and co-founder of TargEDys.
Day 1 | 11:30 - 12:00
Targeting the brain-gut-microbiome axis by ImmuneBioticsTM, a new therapeutic avenue for management of multiple sclerosis
Shahram Lavasani, Founder and CEO at ImmuneBiotech AB
Day 2 | 11:30 - 12:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 1 | 12:00 - 12:30
The gut microbiome as a therapeutic venue for inflammatory diseases of the central nervous system (CNS)
Javier Ochoa-Repáraz, Assistant Professor at Eastern Washington University
Day 2 | 12:00 - 13:00
Panel Discussion
Gut microbiota and its implications for psychiatry: Conclusions and Future Directions for Research
Day 1 | 12:30 - 13:00
Novel Microbiome Approach For Management of Alzheimer Diseases
Satya Prakash, Professor of Biomedical Engineering, Artificial Cells and Organs, Physiology, Experimental Medicine and Surgury in the Faculty of Medicine at McGill University
13:00 - 14:00

Lunch Break

Day 1 | 14:00 - 14:30
Investigating host-microbe interactions and mechanisms of the gut-brain axis in vitro
Eva Maier, Postdoctoral Scientist at AgResearch, Palmerston North, New Zealand
Day 2 | 14:00 - 14:30
TOP-5 Poster Presentations (5min. On Stage)
Click here to submit your poster
Day 1 | 14:30 - 15:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 2 | 14:30 - 15:00
Diet & the Gut-Brain Axis: from concept to product
Marcus Böhme, R&D Specialist at Nestlé Research
15:00 - 15:30

Afternoon Coffee & Networking Break

Day 1 | 15:30 - 16:00
The gut-brain and brain-gut axes in human disease
Wouter de Jonge Professor of Neurogastroenterology at AMC, CoFounder of Gut Research
Day 2 | 15:30 - 16:00
From Nutrition to Therapy: Commercialising the Therapeutic Potential of The Microbiome in the Field of Metabolic Diseases
Georges Rawadi CEO at LNC Therapeutics
Day 1 | 16:00 - 16:30
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 2 | 16:00 - 16:30
Systemic barrier damage and biomarkers connected to inflammation and the potential role in dysbiosis
Domingo Barber Director Institute for Applied Molecular Medicine at Universidad San Pablo Madrid
Day 1 | 16:30 - 17:00
Panel Discussion
Clinical Trials in the Gut-Brain Axis: Challenges & Opportunities
Day 2 | 16:30
Chairman's closing remarks & End of the Gut-Brain Axis

DAY 1 | 20:00 - 22:30

Monday night business dinner

The BioTech Pharma Summit 2021: Gala Dinner

Sponsor this event - Click here
IRDD_Gala_Dinner_New_York_Inhalation_Drug_Delivery

Day 1

Day 2

Day 1 | 08:00 - 08:20

Probiotics, Human & Skin Microbiome Registration & Welcome Coffee

Day 2 | 08:00 - 08:20

Registration for the 2nd day

Day 1 | 08:20 - 08:30

Chairman's Opening Address

Day 2 | 08:20 - 08:30

Opening of the 2nd day of the Probiotics, Human & Skin Microbiome event

Day 1 | 08:30 - 09:00

Skin Care and microbes
Per Falholt, Director at Novo Nordisk Foundation

Day 2 | 08:30 - 09:00

Considering the Microbiome Interorgans Axis (MIA) as a future option in Health & Diseases
Lionel Breton, Scientific Director, Advanced Research at L’Oreal

Day 1 | 09:00 - 09:30

Probiotics, Human & Skin Microbiome Speed Networking
An innovative approach to maximize networking capabilities through two minute periods, where delegates can meet their peers and exchange business cards before rotating to the next company representative.

Day 2 | 09:00 - 09:30

S-Biomedic approach of direct skin microbiome modulation
Veronika Oudova, Co-founder and Chief Executive Officer at S-Biomedic

Day 1 | 09:30 - 10:00

Speaking Sponsorship Available - Have your talk here
Click here to register

Day 2 | 09:30 - 10:00

Speaking Sponsorship Available - Have your talk here
Click here to register

Day 1 | 10:00 - 10:30

Pre-pro-postbiotics and role in modulating our microbiome – status & case studies
Radhika Bongoni, Business Developer at BaseClear B.V.

Day 2 | 10:00 - 10:30

Feeding your brain & skin: will European Regulation let psychobiotics & skinbiotics live up to our expectations?
Elinor McCartney, President for Pen & Tec Consulting
10:30 - 11:00

Morning Coffee & Networking Break

Day 1 | 11:00 - 11:30
Dissecting the human skin microbiome in health and disease
Huiying Li, Associate Professor at University of California, Los Angeles
Day 2 | 11:00 - 11:30
The probiotic potential of SYMPROVE: an in-depth study using the SHIME® technology platform
Frédéric Moens, Head of Research And Development at ProDigest
Day 1 | 11:30 - 12:00
Is human skin microbiota a goldmine for personalized diagnostic tests?
Alexandre Passioukov, Vice President Translational Medicine at Pierre Fabre
Day 2 | 11:30 - 12:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 1 | 12:00 - 12:30
Integrated gut biology
David Berry, General Partner at Flagship Pioneering
Day 2 | 12:00 - 13:00
Panel Discussion
Pre and Probiotics: A Shift from Pharmaceuticals to Nutraceuticals
Day 1 | 12:30 - 13:00
Platform that allows to study the connections among diet, gut microbiome, immune system, human physiology, and health/disease states
Momo Vuyisich, Founder and Chief Science Officer at Viome
13:00 - 14:00

Lunch Break

Day 1 | 14:00 - 14:30
Translating the Human Gut Microbiome- Progress through Innovation and Investment
Denise Kelly, Investment Advisor at Seventure
Day 2 | 14:00 - 14:30
TOP-5 Poster Presentations (5min. On Stage)
Click here to submit your poster
Day 1 | 14:30 - 15:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 2 | 14:30 - 15:00
Speaking Sponsorship Available - Have your talk here
Click here to register
15:00 - 15:30

Afternoon Coffee & Networking Break

Day 1 | 15:30 - 16:00
Ketogenic diet and the gut microbiota
Fabio Piccini Co-founder and Director at Progetto Microbioma Italiano
Day 2 | 15:30 - 16:00
Quality control of probiotics and internationalisation of the ESLP initiative
Jean-Pol Warzée, President at European Scientific League for Probiotics – ESLP
Day 1 | 16:00 - 16:30
Studying the variability of intestinal microbiome in mice to better understand the Human microbiome
Pavlovic Guillaume Head of Unit at PHENOMIN-ICS
Day 2 | 16:00 - 16:30
Topic to be announced
Adam Baker, Director of Science at Chr. Hansen Holding A/S
Day 1 | 16:30 - 17:00
An abnormal microbiome in Anorexia Nervosa – implications for interventions
Magnus Sjögren, PhD Associate Professor at University of Gothenburg
Day 1 | 16:30 - 17:00
Pre-clinical selection of probiotics strains: Six simple steps
Peter Cartwright Human Microecology Specialist
Day 1 | 17:00 - 17:30
Panel Discussion
The Development Of New Therapies In Skin Microbiome
Day 2 | 17:00
Chairman's closing remarks & End of the Probiotics, Human & Skin Microbiome event

DAY 1 | 20:00 - 22:30

Monday night business dinner

The BioTech Pharma Summit 2021: Gala Dinner

Sponsor this event - Click here
IRDD_Gala_Dinner_New_York_Inhalation_Drug_Delivery

Day 1

Day 2

Day 1 | 08:00 - 08:20

Registration & Welcome Coffee

Day 2 | 08:00 - 08:20

Registration and Coffee

Day 1 | 08:20 - 08:30

Chairman's Opening Address

Day 2 | 08:20 - 08:30

Chairman's Opening Address

Day 1 | 08:30 - 09:00

Vaccines for the world - insights into design and execution of a BSL2 fill-finish facility
Matthias Angelmaier, Global Product Manager Isolator Technology at Syntegon Technology GmbH

Day 2 | 08:30 - 09:00

Continuous Processing opening new possibilities
Harald Stahl, Senior Director Innovation and Strategy at GEA AG

Day 1 | 09:00 - 09:30

Speed Networking
An innovative approach to maximize networking capabilities through two minute periods, where delegates can meet their peers and exchange business cards before rotating to the next company representative.

Day 2 | 09:00 - 09:30

Aseptic bag processing: bridging the gap
Christian Kollecker, Business Unit Leader Pharma Liquid / Aseptic at Harro Höfliger

Day 1 | 09:30 - 10:00

Learn How to Trend & Analyze Environmental Monitoring Data
Susan Cleary, Director of Product Development at Novatek International

Day 2 | 09:30 - 10:00

Use of Robotics in Flexible Format Aseptic Filling
Keith W. Dodson, Vice President of Business Development at AST (Automated Systems of Tacoma)

Day 1 | 10:00 - 10:30

Speaking Sponsorship Available - Have your talk here
Click here to register

Day 2 | 10:00 - 10:30

Implementation of an efficient QRM program
Kate Coleman Director/Senior Consultant Quality and Compliance at PharmaLex
10:30 - 11:00

Morning Coffee & Networking Break

Day 1 | 11:00 - 11:30
Innovative and Agile Approaches in the Aseptic Manufacturing of Lyophilised Vialed Drug Products
Dr. Thomas Becker, Director Site Quality at Recipharm
Day 2 | 11:00 - 11:30
Contamination Control Strategy, an Implementation approach.
Walid El Azab, Senior Manager Technical Service at STERIS
Day 1 | 11:30 - 12:00
Combined ATMP Viral vector formulation and filling on an integrated Barrier technology platform
James L. Drinkwater, Head of GMP compliance & Aseptic process integration F Ziel GbmH
Day 2 | 11:30 - 12:00
Decontamination 5.0 -Ultradecon® and Enzyme Indicator-
Ken Nagai Director at Airex Co., Ltd.
Day 1 | 12:00 - 12:30
De-risking the fill and finish process of biotech products
Mostafa Nakach, PhD Head of pharmaceutical engineering section within Pharmaceutical sciences department at Sanofi
Day 2 | 12:00 - 13:00
Panel Discussion
Topic to be announced
Day 1 | 12:30 - 13:00
Speaking Sponsorship Available - Have your talk here
Click here to register
13:00 - 14:00

Lunch Break

Day 1 | 14:00 - 14:30
Closed process for aseptic fill without possibility for sterile filtration
Magnus Gustafsson, Head of Global Business Development at Biovian
Day 2 | 14:00 - 14:30
TOP-5 Poster Presentations (5min. On Stage)
Click here to submit your Poster
Day 1 | 14:30 - 15:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 2 | 14:30 - 15:00
Speaking Sponsorship Available - Have your talk here
Click here to register
15:00 - 15:30

Afternoon Coffee & Networking Break

Day 1 | 15:30 - 16:00
Topic to be announced
Sue Behrens, Professor in Bioprocessing and Director, Amgen Bioprocessing Center at Keck Graduate Institute
Day 2 | 15:30 - 16:00
Contamination and Cross Contamination Control during Aseptic Manufacturing
Richard Denk, Senior Consultant Aseptic Processing & Containment at SKAN AG
Day 1 | 16:00 - 16:30
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 2 | 16:00 - 16:30
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 1 | 16:30 - 17:00

Panel Discussion

Topic to be announced
Day 2 | 16:30
Chairman's closing remarks & End of the IRDD Event

DAY 1 | 20:00 - 22:30

Monday night business dinner

The BioTech Pharma Summit 2021: Gala Dinner

Sponsor this event - Click here
IRDD_Gala_Dinner_New_York_Inhalation_Drug_Delivery

CDx/Biomarkers & Biobanking Agenda

Agenda is being produced and will be announced soon.
Click here to speak at this event
Click here to find the Confirmed speakers
C0019.00_03_18_08.Still092

Slide BIOTECH PHARMA SUMMIT - PORTO / 2021 REGISTER NOW